At the same time, we also demonstrated Tmab upregulates NK cell activation markers, such as CD69 and CD107a, which is consistent with previous reports.27 Accordingly, Tmab enhanced the killing ability of NK cells against GC cells in time-dependent manner. This evidence concerns the gene CD69 and gastric cancer.